TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/5/24 18:10 | 2/29/24 | CYT | Cyteir Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Renschler Markus Md | MA | DO | P,CEO | M.dm | 35 | 1.63 | 0 | 21 | 2 | 1,104 | D | ||||||||||||||
12/14/23 16:00 | 11/20/23 | CYT | Cyteir Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Renschler Markus Md | MA | DO | P,CEO | M.d | 14 | 1.55 | 0 | 9 | 1 | 1,082 | D | ||||||||||||||
11/22/23 13:48 | 11/20/23 | CYT | Cyteir Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Renschler Markus Md | MA | DO | P,CEO | M.d | 129 | 1.53 | 0 | 85 | 9 | 1,073 | D | ||||||||||||||
12/23/22 16:47 | 12/21/22 | CYT | Cyteir Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Renschler Markus Md | MA | DO | P,CEO | M.d | 146 | 1.07 | 0 | 137 | 16 | 979 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |